To amend the Immigration and Nationality Act to clarify the classes of individuals born in the United States who are nationals and citizens of the United States at birth and to provide for the inadmissibility of pregnant aliens who are not married to citizens of the United States seeking admission as nonimmigrants, and for other purposes.
Summary
HR9562 was introduced and referred to the House Judiciary Committee on June 30, 2026. It would restrict nonimmigrant admission for pregnant unmarried aliens and redefine birthright citizenship. The bill is in its earliest legislative stage — no hearings, no markup, no CBO score, and no funding. Near-term market impact is negligible. The affected sectors (healthcare providers, diagnostic labs, managed care) face no measurable earnings risk or opportunity from this procedural referral.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9562 is an early-stage bill with no spending, no funding, and no near-term market impact.
- 2.The bill would reduce US births to undocumented mothers by an estimated <0.5%, an immaterial volume change for hospital and diagnostics companies.
- 3.No related signals or procurements provide legislative momentum; the bill is a standalone member introduction.
- 4.Investors should not trade on this bill — its procedural status and constitutional challenges make it a very long shot.
Market Implications
No market implications at this stage. The bill has not moved markets, and should not — it is a procedural referral with no funding. Healthcare and diagnostic stocks are priced for fundamentals like utilization, reimbursement rates, and regulatory enforcement, not for bills that have not had a single hearing. Investors should ignore this signal until and unless it advances to committee markup.
Full Analysis
What happened: Rep. Andrew Ogles (R-TN5) introduced HR9562 on June 30, 2026, to amend the Immigration and Nationality Act to narrow birthright citizenship and restrict admission of pregnant nonimmigrant aliens who are not married to U.S. citizens. The bill was referred to the House Judiciary Committee, its only committee assignment. This is the first action — no hearings, no markup, no companion in the Senate.
The money trail: The bill authorizes no spending, creates no contracts, appropriates no funds. It is a change to immigration law that, if enacted, would reduce the number of US births to undocumented mothers. The economic mechanism is reduced demand for obstetric and prenatal services among that population. Estimated potential reduction: less than 0.5% of annual US births (based on CDC data showing ~250,000 births to undocumented mothers annually out of ~3.6M total births). For hospital operators like HCA and diagnostic labs like Quest and LabCorp, this represents an immaterial volume shift. For managed care operators UnitedHealthcare and Humana, the impact on Medicaid maternity costs is negligible.
Convergence: No related bills, procurements, or executive actions were provided in the enrichment data. This bill stands alone as a one-off member introduction with no current coalition-building signals.
Structural winners and losers: At this procedural stage, there are no structural winners or losers. The bill has less than a 5% chance of passing the House in its current form, given its controversial birthright-citizenship provision and strong constitutional challenges. Even if it advanced, the healthcare market impact is minimal.
Timeline: The bill must clear House Judiciary Committee, then House floor, then Senate (where a companion would need to be introduced), then survive likely constitutional challenge. This process typically takes years for controversial immigration bills — most die in committee. No further actions are scheduled.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
To amend the Immigration and Nationality Act to impose limits on birthright citizenship for aliens and illegal migrants.
To declare that any person who enters the United States without authorization or for the purpose of engaging in birth tourism is considered an invader and to amend section 301(a) of the Immigration and Nationality Act to exclude the children of invaders from birthright citizenship.
A bill to declare that any person who enters the United States without authorization or for the purpose of engaging in birth tourism is considered an invader and to amend section 301(a) of the Immigration and Nationality Act to exclude the children of invaders from birthright citizenship.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →